VHCP Management III as of June 30, 2019
Portfolio Holdings for VHCP Management III
VHCP Management III holds 17 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals (MIST) | 26.2 | $56M | 2.1M | 27.15 | |
| Axsome Therapeutics (AXSM) | 19.4 | $42M | 1.6M | 25.75 | |
| Ra Pharmaceuticals | 9.4 | $20M | 670k | 30.07 | |
| Kalvista Pharmaceuticals (KALV) | 6.6 | $14M | 638k | 22.15 | |
| Obseva Sa | 6.1 | $13M | 1.2M | 11.31 | |
| Protagonist Therapeutics (PTGX) | 6.1 | $13M | 1.1M | 12.11 | |
| La Jolla Pharmaceuticl Com Par | 5.4 | $12M | 1.3M | 9.25 | |
| Tricida | 5.3 | $11M | 290k | 39.46 | |
| BioCryst Pharmaceuticals (BCRX) | 4.8 | $10M | 2.7M | 3.79 | |
| Orchard Therapeutics Plc ads | 4.4 | $9.5M | 676k | 13.99 | |
| Marinus Pharmaceuticals | 2.4 | $5.2M | 1.3M | 4.15 | |
| Kiniksa Pharmaceuticals (KNSA) | 2.0 | $4.2M | 312k | 13.54 | |
| Bellerophon Therapeutics | 0.7 | $1.5M | 2.4M | 0.60 | |
| Kadmon Hldgs | 0.4 | $870k | 422k | 2.06 | |
| Constellation Pharmceticls I | 0.4 | $819k | 67k | 12.28 | |
| Gemphire Therapeutics | 0.3 | $646k | 798k | 0.81 | |
| Proteostasis Therapeutics In | 0.1 | $217k | 221k | 0.98 |
